BioXcel Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of BTAI for the last quarter is 376.00 k USD, and it's 10.26% higher compared to the previous quarter. The net income of Q4 23 is -22.26 M USD.